PubRank

D C Wheeler

Author PubWeight™ 41.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007 7.75
2 Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001 1.64
3 Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000 1.43
4 Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant 1997 1.41
5 Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet 1995 1.26
6 Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004 1.23
7 Anaphylactoid reaction to acetylcysteine. Lancet 1982 1.11
8 Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 1987 1.04
9 Experience with a new method for percutaneous renal biopsy. Nephrol Dial Transplant 1991 0.98
10 Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int 2001 0.96
11 Glomerular structures and lipids in progressive renal disease. Am J Med 1989 0.95
12 Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM 1997 0.92
13 Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells. Kidney Int 1996 0.92
14 Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 1993 0.90
15 Lipid abnormalities in renal disease. J R Soc Med 2000 0.86
16 Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells. Kidney Int 1999 0.86
17 Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. Br Med J (Clin Res Ed) 1984 0.85
18 Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. Ren Fail 1987 0.85
19 Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem Soc Trans 2004 0.84
20 A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J Am Coll Cardiol 2001 0.84
21 Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000 0.84
22 Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant 1998 0.83
23 High risk acute renal failure. Q J Med 1986 0.83
24 Vancomycin-dependent enterococci in a uraemic patient with sclerosing peritonitis. Nephrol Dial Transplant 1999 0.81
25 A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 1987 0.80
26 Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004 0.80
27 Evolution and etiology of cardiovascular diseases in renal transplant recipients. Transplantation 2000 0.80
28 Pulmonary-renal syndrome in association with anti-GBM and IgM ANCA. Lancet 1992 0.79
29 Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection. Nephrol Dial Transplant 1989 0.79
30 Listeria monocytogenes CAPD peritonitis: failure of vancomycin therapy. J Antimicrob Chemother 1994 0.79
31 Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? Nephrol Dial Transplant 2000 0.78
32 Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis. Nephrol Dial Transplant 2000 0.78
33 Renal amyloidosis and angioimmunoblastic lymphadenopathy. Nephrol Dial Transplant 1998 0.77
34 Vitamin E supplementation. Lancet 2001 0.77
35 Audiometric configuration in patients being treated for alcoholism. Drug Alcohol Depend 1980 0.77
36 Lipids--what is the evidence for their role in progressive renal disease? Nephrol Dial Transplant 1995 0.77
37 Effects of omega-3 fatty acids on complement-mediated glomerular epithelial cell injury. Kidney Int 1996 0.76
38 Carbimazole-induced jaundice. J R Soc Med 1985 0.75
39 A difficult pain in the neck. Br Med J (Clin Res Ed) 1985 0.75
40 Lipid-lowering drugs and homocysteine. Lancet 1999 0.75
41 Butterfat absorption--a valuable screening test in malabsorption. Postgrad Med J 1994 0.75
42 Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1986 0.75
43 Ischaemic heart disease after renal transplantation: how to assess and minimize the risk. Nephrol Dial Transplant 1999 0.75
44 Fish oil ameliorates renal injury and hyperlipidemia in the Milan normotensive rat model of focal glomerulosclerosis. J Am Soc Nephrol 1995 0.75
45 Should hyperlipidaemia in dialysis patients be treated? Nephrol Dial Transplant 1997 0.75